Table 4 Laboratory index in TLS patients with different outcome.
From: Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia
Event-free survival (n = 71, %) | Relapse and death (n = 7, %) | OR (95% CI) | |
|---|---|---|---|
WBCa | |||
< 50 × 109/L | 46.5 | 28.6 | 1.00 |
≥ 50 × 109/L | 53.5 | 71.4 | 2.2 (0.4–11.9) |
Hyperkalemia | |||
No | 62.0 | 85.7 | 1.00 |
Yes | 38.0 | 14.3 | 0.2 (0.0–2.4) |
Hyperphosphatemia | |||
No | 29.6 | 57.1 | 1.00 |
Yes | 70.4 | 42.9 | 0.3 (0.1–1.5) |
Hyperuricemia | |||
No | 45.1 | 28.6 | 1.00 |
Yes | 54.9 | 71.4 | 2.1 (0.4–11.3) |
Hypocalcemia | |||
No | 50.7 | 42.9 | 1.00 |
Yes | 49.3 | 57.1 | 1.4 (0.3–6.6) |
Elevated creatinine | |||
No | 57.7 | 57.1 | 1.00 |
Yes | 42.3 | 42.9 | 1.0 (0.2–4.9) |
